Micrima raises $7.9m to expand its breast imaging technology.
The Bristol spinout has increased its total funding to $10.7m following earlier backing from the University Enterprise Fund and SetSquared.
Micrima is a breast imaging spinout based in Bristol that develops medical technology for early detection. The company uses radio-wave technology as an alternative to traditional mammography.
Bristol-based breast imaging company Micrima has increased its total funding to $10.7m, bringing its latest round intake to $7.9m. The spinout previously received backing from the University Enterprise Fund and SetSquared. The new capital will support further development of its radio-wave imaging technology as the company expands its market presence.
The firm continues to advance its diagnostic tools, which are designed to offer a safer and more comfortable screening process for patients. With this additional financial backing, Micrima aims to accelerate commercial deployment and clinical trials.
Categories
About the company
Micrima
Micrima develops radio-wave breast imaging technology for clinical use.